LF
DXCM icon

Lee Financial’s DexCom DXCM Stock Holding History

Lee Financial’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36
Closed -$4.47K – 350
2023
Q4 		$4.47K Sell
36
-22
-38% -$2.25K ﹤0.01% 571
2023
Q3 		$5.41K Hold
58
– – ﹤0.01% 507
2023
Q2 		$7.46K Hold
58
– – ﹤0.01% 454
2023
Q1 		$6.74K Sell
58
-3
-5% -$336 ﹤0.01% 482
2022
Q4 		$6.91K Hold
61
– – ﹤0.01% 507
2022
Q3 		$5K Buy
61
+9
+17% +$762 ﹤0.01% 533
2022
Q2 		$4K Buy
52
+36
+225% +$3.29K ﹤0.01% 583
2022
Q1 		$2K Hold
16
– – ﹤0.01% 634
2021
Q4 		$2K Hold
16
– – ﹤0.01% 728
2021
Q3 		$2K Hold
16
– – ﹤0.01% 609
2021
Q2 		$2K Sell
16
-24
-60% -$2.31K ﹤0.01% 562
2021
Q1 		$4K Hold
40
– – ﹤0.01% 437
2020
Q4 		$4K Hold
40
– – ﹤0.01% 430
2020
Q3 		$4K Hold
40
– – ﹤0.01% 472
2020
Q2 		$4K Hold
40
– – ﹤0.01% 443
2020
Q1 		$3K Buy
+40
New +$2.49K ﹤0.01% 408

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lee Financial's DXCM Position: Q1 2024 in Review

Lee Financial sold out of DexCom (DXCM) in Q1 2024, closing a stake of 36 shares — an estimated $4.47K sold.

Lee Financial first reported a position in DXCM in Q1 2020 and held it in 16 quarters. The position peaked at $7.46K in Q2 2023. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Lee Financial reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 36 DexCom shares in Q1 2024, an estimated $4.47K.
  • Lee Financial first reported a position in DexCom in Q1 2020 and held it in 16 quarters.
  • Lee Financial's DexCom position peaked at $7.46K in Q2 2023.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.